{"transactions":[{"id":802554,"issuer":{"id":8471,"kind":"organization","name":"Onconetix, Inc."},"owners":[{"id":202,"kind":"organization","name":"HRT FINANCIAL LP","position":1,"cik":"0001475597","reported_name":"HRT FINANCIAL LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Shares","published_at":"2026-04-22T18:59:05.000Z","date":"2026-04-21","kind":"sale","planned":false,"acquired":false,"shares":49710,"price":0.69,"value":34299.9,"ownership":{"direct":true},"balance_after":33649,"source":{"system":"sec-edgar","filing":"0001475597-26-000019","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1475597/000147559726000019/primary_doc.xml","form_type":"4"}},{"id":803548,"issuer":{"id":8471,"kind":"organization","name":"Onconetix, Inc."},"owners":[{"id":202,"kind":"organization","name":"HRT FINANCIAL LP","position":1,"cik":"0001475597","reported_name":"HRT FINANCIAL LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Shares","published_at":"2026-04-21T19:41:33.000Z","date":"2026-04-20","kind":"sale","planned":false,"acquired":false,"shares":94462,"price":0.75,"value":70846.5,"ownership":{"direct":true},"balance_after":83359,"source":{"system":"sec-edgar","filing":"0001475597-26-000018","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1475597/000147559726000018/primary_doc.xml","form_type":"4"}},{"id":803547,"issuer":{"id":8471,"kind":"organization","name":"Onconetix, Inc."},"owners":[{"id":202,"kind":"organization","name":"HRT FINANCIAL LP","position":1,"cik":"0001475597","reported_name":"HRT FINANCIAL LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Shares","published_at":"2026-04-21T19:41:33.000Z","date":"2026-04-17","kind":"purchase","planned":false,"acquired":true,"shares":34636,"price":0.73,"value":25284.28,"ownership":{"direct":true},"balance_after":177821,"source":{"system":"sec-edgar","filing":"0001475597-26-000018","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1475597/000147559726000018/primary_doc.xml","form_type":"4"}},{"id":803546,"issuer":{"id":8471,"kind":"organization","name":"Onconetix, Inc."},"owners":[{"id":202,"kind":"organization","name":"HRT FINANCIAL LP","position":1,"cik":"0001475597","reported_name":"HRT FINANCIAL LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Shares","published_at":"2026-04-21T19:41:33.000Z","date":"2026-04-16","kind":"sale","planned":false,"acquired":false,"shares":53867,"price":0.73,"value":39322.91,"ownership":{"direct":true},"balance_after":143185,"source":{"system":"sec-edgar","filing":"0001475597-26-000018","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1475597/000147559726000018/primary_doc.xml","form_type":"4"}},{"id":806870,"issuer":{"id":8471,"kind":"organization","name":"Onconetix, Inc."},"owners":[{"id":202,"kind":"organization","name":"HRT FINANCIAL LP","position":1,"cik":"0001475597","reported_name":"HRT FINANCIAL LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Shares","published_at":"2026-04-16T18:30:24.000Z","date":"2026-04-15","kind":"purchase","planned":false,"acquired":true,"shares":92554,"price":0.76,"value":70341.04,"ownership":{"direct":true},"balance_after":197052,"source":{"system":"sec-edgar","filing":"0001475597-26-000017","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1475597/000147559726000017/primary_doc.xml","form_type":"4"}},{"id":806869,"issuer":{"id":8471,"kind":"organization","name":"Onconetix, Inc."},"owners":[{"id":202,"kind":"organization","name":"HRT FINANCIAL LP","position":1,"cik":"0001475597","reported_name":"HRT FINANCIAL LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Shares","published_at":"2026-04-16T18:30:24.000Z","date":"2026-04-14","kind":"purchase","planned":false,"acquired":true,"shares":74350,"price":0.77,"value":57249.5,"ownership":{"direct":true},"balance_after":104498,"source":{"system":"sec-edgar","filing":"0001475597-26-000017","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1475597/000147559726000017/primary_doc.xml","form_type":"4"}},{"id":1062269,"issuer":{"id":8471,"kind":"organization","name":"Onconetix, Inc."},"owners":[{"id":43566,"kind":"person","name":"Oakley Andrew John","position":1,"cik":"0002059152","reported_name":"Oakley Andrew John","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-08-19T20:05:29.000Z","date":"2025-08-15","kind":"grant","planned":false,"acquired":true,"shares":618,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents a restricted stock award granted to the Reporting Person pursuant to the 2022 Plan. The award will vest in full on August 31, 2026 so long as the Reporting Person continues to serve as a non-employee director of the Issuer until such date."}],"balance_after":638,"source":{"system":"sec-edgar","filing":"0001213900-25-078489","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2059152/000121390025078489/ownership.xml","form_type":"4"}},{"id":1062268,"issuer":{"id":8471,"kind":"organization","name":"Onconetix, Inc."},"owners":[{"id":43566,"kind":"person","name":"Oakley Andrew John","position":1,"cik":"0002059152","reported_name":"Oakley Andrew John","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-08-19T20:05:29.000Z","date":"2025-08-15","kind":"other","planned":false,"acquired":true,"shares":20,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a restricted stock award originally granted to the Reporting Person on March 23, 2025 pursuant to the Issuer's 2022 Equity Incentive Plan, as amended (\"2022 Plan\" and the grant on such date, the \"Original Award\"). On August 15, 2025, the Original Award was modified to change the vesting terms, such that the award, which was to vest in full on August 31, 2025, was changed to vest in full on August 31, 2026, so long as the Reporting Person continues to serve as a non-employee director of the Issuer until such date. Except as set forth herein, the Original Award remains unmodified."},{"field":"shares","element":"transactionShares","label":"F2","text":"On June 13, 2025, the Issuer effected a 1-for-85 reverse split of its Common Stock. The amounts set forth herein are presented on a post-split basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"On June 13, 2025, the Issuer effected a 1-for-85 reverse split of its Common Stock. The amounts set forth herein are presented on a post-split basis."}],"balance_after":20,"source":{"system":"sec-edgar","filing":"0001213900-25-078489","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2059152/000121390025078489/ownership.xml","form_type":"4"}},{"id":1061076,"issuer":{"id":8471,"kind":"organization","name":"Onconetix, Inc."},"owners":[{"id":76327,"kind":"person","name":"Meier Thomas","position":1,"cik":"0002010924","reported_name":"Meier Thomas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-08-19T20:05:25.000Z","date":"2025-08-15","kind":"grant","planned":false,"acquired":true,"shares":618,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents a restricted stock award granted to the Reporting Person pursuant to the 2022 Plan. The award will vest in full on August 31, 2026 so long as the Reporting Person continues to serve as a non-employee director of the Issuer until such date."}],"balance_after":657,"source":{"system":"sec-edgar","filing":"0001213900-25-078487","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1782107/000121390025078487/ownership.xml","form_type":"4"}},{"id":1061075,"issuer":{"id":8471,"kind":"organization","name":"Onconetix, Inc."},"owners":[{"id":76327,"kind":"person","name":"Meier Thomas","position":1,"cik":"0002010924","reported_name":"Meier Thomas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-08-19T20:05:25.000Z","date":"2025-08-15","kind":"other","planned":false,"acquired":true,"shares":39,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a restricted stock award originally granted to the Reporting Person on September 26, 2024 pursuant to the Issuer's 2022 Equity Incentive Plan, as amended (\"2022 Plan\" and the grant on such date, the \"Original Award\"). On August 15, 2025, the Original Award was modified to change the vesting terms, such that the award, which was to vest in full on August 31, 2025, was changed to vest in full on August 31, 2026, so long as the Reporting Person continues to serve as a non-employee director of the Issuer until such date. Except as set forth herein, the Original Award remains unmodified."},{"field":"shares","element":"transactionShares","label":"F2","text":"On June 13, 2025, the Issuer effected a 1-for-85 reverse split of its Common Stock. The amounts set forth herein are presented on a post-split basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"On June 13, 2025, the Issuer effected a 1-for-85 reverse split of its Common Stock. The amounts set forth herein are presented on a post-split basis."}],"balance_after":39,"source":{"system":"sec-edgar","filing":"0001213900-25-078487","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1782107/000121390025078487/ownership.xml","form_type":"4"}},{"id":1061074,"issuer":{"id":8471,"kind":"organization","name":"Onconetix, Inc."},"owners":[{"id":42231,"kind":"person","name":"Ramdeen Timothy R.","position":1,"cik":"0001962363","reported_name":"Ramdeen Timothy R.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-08-19T20:05:17.000Z","date":"2025-08-15","kind":"grant","planned":false,"acquired":true,"shares":618,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents a restricted stock award granted to the Reporting Person pursuant to the 2022 Plan. The award will vest in full on August 31, 2026 so long as the Reporting Person continues to serve as a non-employee director of the Issuer until such date."}],"balance_after":658,"source":{"system":"sec-edgar","filing":"0001213900-25-078484","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1782107/000121390025078484/ownership.xml","form_type":"4"}},{"id":1061073,"issuer":{"id":8471,"kind":"organization","name":"Onconetix, Inc."},"owners":[{"id":42231,"kind":"person","name":"Ramdeen Timothy R.","position":1,"cik":"0001962363","reported_name":"Ramdeen Timothy R.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-08-19T20:05:17.000Z","date":"2025-08-15","kind":"other","planned":false,"acquired":true,"shares":39,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a restricted stock award originally granted to the Reporting Person on September 26, 2024 pursuant to the Issuer's 2022 Equity Incentive Plan, as amended (\"2022 Plan\" and the grant on such date, the \"Original Award\"). On August 15, 2025, the Original Award was modified to change the vesting terms, such that the award, which was to vest in full on August 31, 2025, was changed to vest in full on August 31, 2026, so long as the Reporting Person continues to serve as a non-employee director of the Issuer until such date. Except as set forth herein, the Original Award remains unmodified."},{"field":"shares","element":"transactionShares","label":"F2","text":"On June 13, 2025, the Issuer effected a 1-for-85 reverse split of its Common Stock. The amounts set forth herein are presented on a post-split basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"On June 13, 2025, the Issuer effected a 1-for-85 reverse split of its Common Stock. The amounts set forth herein are presented on a post-split basis."}],"balance_after":40,"source":{"system":"sec-edgar","filing":"0001213900-25-078484","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1782107/000121390025078484/ownership.xml","form_type":"4"}},{"id":1062089,"issuer":{"id":8471,"kind":"organization","name":"Onconetix, Inc."},"owners":[{"id":76342,"kind":"person","name":"Tarsh Simon","position":1,"cik":"0001943931","reported_name":"Tarsh Simon","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-08-19T16:05:27.000Z","date":"2025-08-15","kind":"grant","planned":false,"acquired":true,"shares":618,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents a restricted stock award granted to the Reporting Person pursuant to the 2022 Plan. The award will vest in full on August 31, 2026 so long as the Reporting Person continues to serve as a non-employee director of the Issuer until such date."}],"balance_after":658,"source":{"system":"sec-edgar","filing":"0001213900-25-078488","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1943931/000121390025078488/ownership.xml","form_type":"4"}},{"id":1062088,"issuer":{"id":8471,"kind":"organization","name":"Onconetix, Inc."},"owners":[{"id":76342,"kind":"person","name":"Tarsh Simon","position":1,"cik":"0001943931","reported_name":"Tarsh Simon","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-08-19T16:05:27.000Z","date":"2025-08-15","kind":"other","planned":false,"acquired":true,"shares":39,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a restricted stock award originally granted to the Reporting Person on September 26, 2024 pursuant to the Issuer's 2022 Equity Incentive Plan, as amended (\"2022 Plan\" and the grant on such date, the \"Original Award\"). On August 15, 2025, the Original Award was modified to change the vesting terms, such that the award, which was to vest in full on August 31, 2025, was changed to vest in full on August 31, 2026, so long as the Reporting Person continues to serve as a non-employee director of the Issuer until such date. Except as set forth herein, the Original Award remains unmodified."},{"field":"shares","element":"transactionShares","label":"F2","text":"On June 13, 2025, the Issuer effected a 1-for-85 reverse split of its Common Stock. The amounts set forth herein are presented on a post-split basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"On June 13, 2025, the Issuer effected a 1-for-85 reverse split of its Common Stock. The amounts set forth herein are presented on a post-split basis."}],"balance_after":40,"source":{"system":"sec-edgar","filing":"0001213900-25-078488","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1943931/000121390025078488/ownership.xml","form_type":"4"}},{"id":1086718,"issuer":{"id":8471,"kind":"organization","name":"Onconetix, Inc."},"owners":[{"id":77483,"kind":"organization","name":"Altos Venture AG","position":1,"cik":"0002006260","reported_name":"Altos Venture AG","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Make-whole right (right to acquire)","published_at":"2025-07-16T16:03:52.000Z","date":"2025-07-14","kind":"other","planned":false,"acquired":false,"shares":241514,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"1.\tPursuant to a Subscription Agreement with the Issuer dated December 15, 2023, the Reporting Person purchased Units of Common Stock and warrants (immediately exercised) on September 24, 2024. Under a \"make-whole\" provision in the Subscription Agreement, the Issuer agreed to adjust the price for the Units by issuing additional shares of Common Stock to the Reporting Person based on the Issuer VWAP (as defined in the Subscription Agreement) during a specified period following the purchase.  At the end of the period, the number of additional shares to be issued was determined to be 241,514, and those shares were issued to the Reporting Person on July 14, 2025 pursuant to the \"make-whole\" provision."},{"field":"kind","element":"transactionCoding","label":"F1","text":"1.\tPursuant to a Subscription Agreement with the Issuer dated December 15, 2023, the Reporting Person purchased Units of Common Stock and warrants (immediately exercised) on September 24, 2024. Under a \"make-whole\" provision in the Subscription Agreement, the Issuer agreed to adjust the price for the Units by issuing additional shares of Common Stock to the Reporting Person based on the Issuer VWAP (as defined in the Subscription Agreement) during a specified period following the purchase.  At the end of the period, the number of additional shares to be issued was determined to be 241,514, and those shares were issued to the Reporting Person on July 14, 2025 pursuant to the \"make-whole\" provision."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"1.\tPursuant to a Subscription Agreement with the Issuer dated December 15, 2023, the Reporting Person purchased Units of Common Stock and warrants (immediately exercised) on September 24, 2024. Under a \"make-whole\" provision in the Subscription Agreement, the Issuer agreed to adjust the price for the Units by issuing additional shares of Common Stock to the Reporting Person based on the Issuer VWAP (as defined in the Subscription Agreement) during a specified period following the purchase.  At the end of the period, the number of additional shares to be issued was determined to be 241,514, and those shares were issued to the Reporting Person on July 14, 2025 pursuant to the \"make-whole\" provision."}],"balance_after":0,"derivative":{"exercise_date":"2025-07-14","expiration_date":"2025-07-14","underlying":"Common Stock","underlying_shares":241514},"source":{"system":"sec-edgar","filing":"0001415889-25-019831","document":"form4-07162025_080748.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2006260/000141588925019831/form4-07162025_080748.xml","form_type":"4"}},{"id":1086717,"issuer":{"id":8471,"kind":"organization","name":"Onconetix, Inc."},"owners":[{"id":77483,"kind":"organization","name":"Altos Venture AG","position":1,"cik":"0002006260","reported_name":"Altos Venture AG","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-07-16T16:03:52.000Z","date":"2025-07-14","kind":"other","planned":false,"acquired":true,"shares":241514,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"1.\tPursuant to a Subscription Agreement with the Issuer dated December 15, 2023, the Reporting Person purchased Units of Common Stock and warrants (immediately exercised) on September 24, 2024. Under a \"make-whole\" provision in the Subscription Agreement, the Issuer agreed to adjust the price for the Units by issuing additional shares of Common Stock to the Reporting Person based on the Issuer VWAP (as defined in the Subscription Agreement) during a specified period following the purchase.  At the end of the period, the number of additional shares to be issued was determined to be 241,514, and those shares were issued to the Reporting Person on July 14, 2025 pursuant to the \"make-whole\" provision."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"1.\tPursuant to a Subscription Agreement with the Issuer dated December 15, 2023, the Reporting Person purchased Units of Common Stock and warrants (immediately exercised) on September 24, 2024. Under a \"make-whole\" provision in the Subscription Agreement, the Issuer agreed to adjust the price for the Units by issuing additional shares of Common Stock to the Reporting Person based on the Issuer VWAP (as defined in the Subscription Agreement) during a specified period following the purchase.  At the end of the period, the number of additional shares to be issued was determined to be 241,514, and those shares were issued to the Reporting Person on July 14, 2025 pursuant to the \"make-whole\" provision."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"On September 24, 2024, the Issuer effected a 1-for-40 reverse split of its Common Stock, and on June 13, 2025, the Issuer effected a 1-for-85 reverse split of its Common Stock."}],"balance_after":273230,"source":{"system":"sec-edgar","filing":"0001415889-25-019831","document":"form4-07162025_080748.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2006260/000141588925019831/form4-07162025_080748.xml","form_type":"4"}},{"id":1192478,"issuer":{"id":8471,"kind":"organization","name":"Onconetix, Inc."},"owners":[{"id":43566,"kind":"person","name":"Oakley Andrew John","position":1,"cik":"0002059152","reported_name":"Oakley Andrew John","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-03-25T19:44:38.000Z","date":"2025-03-23","kind":"grant","planned":false,"acquired":true,"shares":1709,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On March 23, 2025, the Reporting Person was granted 1,709 restricted stock units, which will be settled in shares of common stock, par value $0.00001. The restricted stock units fully vest on August 31, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes unvested RSUs."}],"balance_after":1709,"source":{"system":"sec-edgar","filing":"0001013762-25-002105","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2059152/000101376225002105/ownership.xml","form_type":"4"}},{"id":1297888,"issuer":{"id":8471,"kind":"organization","name":"Onconetix, Inc."},"owners":[{"id":83976,"kind":"person","name":"Schiess Ralph","position":1,"cik":"0002006201","reported_name":"Schiess Ralph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CEO, CSO"}}],"security":"Common Stock","published_at":"2025-01-22T16:15:13.000Z","date":"2024-12-20","kind":"grant","planned":false,"acquired":true,"shares":177462,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of Common Stock of the Issuer issuable upon settlement of Restricted Stock Units."}],"balance_after":673365,"source":{"system":"sec-edgar","filing":"0001213900-25-005492","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2006201/000121390025005492/ownership.xml","form_type":"4"}},{"id":1297887,"issuer":{"id":8471,"kind":"organization","name":"Onconetix, Inc."},"owners":[{"id":83975,"kind":"person","name":"Bruhlmann Christian","position":1,"cik":"0002006197","reported_name":"Bruhlmann Christian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Strategy Officer"}}],"security":"Common Stock","published_at":"2025-01-22T16:15:12.000Z","date":"2024-12-20","kind":"grant","planned":false,"acquired":true,"shares":177462,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of Common Stock of the Issuer issuable upon settlement of Restricted Stock Units."}],"balance_after":611372,"source":{"system":"sec-edgar","filing":"0001213900-25-005491","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2006197/000121390025005491/ownership.xml","form_type":"4"}},{"id":1397723,"issuer":{"id":8471,"kind":"organization","name":"Onconetix, Inc."},"owners":[{"id":42231,"kind":"person","name":"Ramdeen Timothy R.","position":1,"cik":"0001962363","reported_name":"Ramdeen Timothy R.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-09-30T23:11:04.000Z","date":"2024-09-26","kind":"grant","planned":false,"acquired":true,"shares":3318,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a restricted stock award granted to the Reporting Person pursuant to the Issuer's 2022 Equity Incentive Plan, as amended. The award will vest in full on August 31, 2025 so long as the Reporting Person continues to serve as a non-employee director of the Issuer until such date."}],"balance_after":3477,"source":{"system":"sec-edgar","filing":"0001213900-24-083521","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1782107/000121390024083521/ownership.xml","form_type":"4"}},{"id":1397722,"issuer":{"id":8471,"kind":"organization","name":"Onconetix, Inc."},"owners":[{"id":76327,"kind":"person","name":"Meier Thomas","position":1,"cik":"0002010924","reported_name":"Meier Thomas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-09-30T23:10:50.000Z","date":"2024-09-26","kind":"grant","planned":false,"acquired":true,"shares":3318,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a restricted stock award granted to the Reporting Person pursuant to the Issuer's 2022 Equity Incentive Plan, as amended. The award will vest in full on August 31, 2025 so long as the Reporting Person continues to serve as a non-employee director of the Issuer until such date."}],"balance_after":3318,"source":{"system":"sec-edgar","filing":"0001213900-24-083520","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1782107/000121390024083520/ownership.xml","form_type":"4"}},{"id":1397985,"issuer":{"id":8471,"kind":"organization","name":"Onconetix, Inc."},"owners":[{"id":76342,"kind":"person","name":"Tarsh Simon","position":1,"cik":"0001943931","reported_name":"Tarsh Simon","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-09-30T19:11:45.000Z","date":"2024-09-26","kind":"grant","planned":false,"acquired":true,"shares":3318,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a restricted stock award granted to the Reporting Person pursuant to the Issuer's 2022 Equity Incentive Plan, as amended. The award will vest in full on August 31, 2025 so long as the Reporting Person continues to serve as a non-employee director of the Issuer until such date."}],"balance_after":3477,"source":{"system":"sec-edgar","filing":"0001213900-24-083524","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1943931/000121390024083524/ownership.xml","form_type":"4"}},{"id":1397772,"issuer":{"id":8471,"kind":"organization","name":"Onconetix, Inc."},"owners":[{"id":87197,"kind":"person","name":"SINGH AJIT","position":1,"cik":"0001590946","reported_name":"SINGH AJIT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-09-30T19:11:32.000Z","date":"2024-09-26","kind":"grant","planned":false,"acquired":true,"shares":3318,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a restricted stock award granted to the Reporting Person pursuant to the Issuer's 2022 Equity Incentive Plan, as amended. The award will vest in full on August 31, 2025 so long as the Reporting Person continues to serve as a non-employee director of the Issuer until such date."}],"balance_after":3396,"source":{"system":"sec-edgar","filing":"0001213900-24-083523","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1590946/000121390024083523/ownership.xml","form_type":"4"}},{"id":1397788,"issuer":{"id":8471,"kind":"organization","name":"Onconetix, Inc."},"owners":[{"id":41703,"kind":"person","name":"SAPIRSTEIN JAMES","position":1,"cik":"0001559509","reported_name":"SAPIRSTEIN JAMES","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-09-30T19:11:18.000Z","date":"2024-09-26","kind":"grant","planned":false,"acquired":true,"shares":3318,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a restricted stock award granted to the Reporting Person pursuant to the Issuer's 2022 Equity Incentive Plan, as amended. The award will vest in full on August 31, 2025 so long as the Reporting Person continues to serve as a non-employee director of the Issuer until such date."}],"balance_after":3477,"source":{"system":"sec-edgar","filing":"0001213900-24-083522","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1559509/000121390024083522/ownership.xml","form_type":"4"}},{"id":1399043,"issuer":{"id":8471,"kind":"organization","name":"Onconetix, Inc."},"owners":[{"id":83975,"kind":"person","name":"Bruhlmann Christian","position":1,"cik":"0002006197","reported_name":"Bruhlmann Christian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Strategy Officer"}}],"security":"Common Stock","published_at":"2024-09-26T16:05:34.000Z","date":"2024-09-24","kind":"grant","planned":false,"acquired":true,"shares":428010,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of common stock of the Issuer issued to the Reporting Person upon automatic conversion of Series B preferred stock (\"Preferred Shares\") of the Issuer, in accordance with the Certificate of Designation for the Preferred Shares."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents shares of common stock of the Issuer issued to the Reporting Person upon automatic conversion of Series B preferred stock (\"Preferred Shares\") of the Issuer, in accordance with the Certificate of Designation for the Preferred Shares."}],"balance_after":433910,"source":{"system":"sec-edgar","filing":"0001213900-24-082239","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2006197/000121390024082239/ownership.xml","form_type":"4"}},{"id":1399044,"issuer":{"id":8471,"kind":"organization","name":"Onconetix, Inc."},"owners":[{"id":83976,"kind":"person","name":"Schiess Ralph","position":1,"cik":"0002006201","reported_name":"Schiess Ralph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CEO & CSO"}}],"security":"Common Stock","published_at":"2024-09-26T16:05:32.000Z","date":"2024-09-24","kind":"grant","planned":false,"acquired":true,"shares":489160,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of common stock of the Issuer issued to the Reporting Person upon automatic conversion of Series B preferred stock (\"Preferred Shares\") of the Issuer, in accordance with the Certificate of Designation for the Preferred Shares."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents shares of common stock of the Issuer issued to the Reporting Person upon automatic conversion of Series B preferred stock (\"Preferred Shares\") of the Issuer, in accordance with the Certificate of Designation for the Preferred Shares."}],"balance_after":495903,"source":{"system":"sec-edgar","filing":"0001213900-24-082238","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2006201/000121390024082238/ownership.xml","form_type":"4"}},{"id":1628077,"issuer":{"id":8471,"kind":"organization","name":"Onconetix, Inc."},"owners":[{"id":87197,"kind":"person","name":"SINGH AJIT","position":1,"cik":"0001590946","reported_name":"SINGH AJIT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-02-21T16:05:28.000Z","date":"2024-02-16","kind":"grant","planned":false,"acquired":true,"shares":3125,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a restricted stock award granted to the Reporting Person pursuant to the Issuer's 2022 Equity Incentive Plan, as amended. The award will vest in full on June 14, 2024, so long as the Reporting Person continues to serve as a non-employee director of the Issuer until such date."}],"balance_after":3125,"source":{"system":"sec-edgar","filing":"0001213900-24-015752","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1590946/000121390024015752/ownership.xml","form_type":"4"}},{"id":1871577,"issuer":{"id":8471,"kind":"organization","name":"Onconetix, Inc."},"owners":[{"id":47712,"kind":"person","name":"Jeremic Vuk","position":1,"cik":"0001953202","reported_name":"Jeremic Vuk","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-02T01:11:50.000Z","date":"2023-05-31","kind":"grant","planned":false,"acquired":true,"shares":6360,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a restricted stock award granted to the Reporting Person pursuant to the Issuer's 2022 Equity Incentive Plan, as amended. The award will vest in full on May 31, 2024 so long as the Reporting Person continues to serve as a non-employee director of the Issuer until such date."}],"balance_after":6360,"source":{"system":"sec-edgar","filing":"0001213900-23-045327","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1782107/000121390023045327/ownership.xml","form_type":"4"}},{"id":1871576,"issuer":{"id":8471,"kind":"organization","name":"Onconetix, Inc."},"owners":[{"id":42231,"kind":"person","name":"Ramdeen Timothy R.","position":1,"cik":"0001962363","reported_name":"Ramdeen Timothy R.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-02T01:11:20.000Z","date":"2023-05-31","kind":"grant","planned":false,"acquired":true,"shares":6360,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a restricted stock award granted to the Reporting Person pursuant to the Issuer's 2022 Equity Incentive Plan, as amended. The award will vest in full on May 31, 2024 so long as the Reporting Person continues to serve as a non-employee director of the Issuer until such date."}],"balance_after":6360,"source":{"system":"sec-edgar","filing":"0001213900-23-045326","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1782107/000121390023045326/ownership.xml","form_type":"4"}},{"id":1872296,"issuer":{"id":8471,"kind":"organization","name":"Onconetix, Inc."},"owners":[{"id":76342,"kind":"person","name":"Tarsh Simon","position":1,"cik":"0001943931","reported_name":"Tarsh Simon","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-01T21:10:44.000Z","date":"2023-05-31","kind":"grant","planned":false,"acquired":true,"shares":6360,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a restricted stock award granted to the Reporting Person pursuant to the Issuer's 2022 Equity Incentive Plan, as amended. The award will vest in full on May 31, 2024 so long as the Reporting Person continues to serve as a non-employee director of the Issuer until such date."}],"balance_after":6360,"source":{"system":"sec-edgar","filing":"0001213900-23-045324","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1943931/000121390023045324/ownership.xml","form_type":"4"}},{"id":1871671,"issuer":{"id":8471,"kind":"organization","name":"Onconetix, Inc."},"owners":[{"id":41703,"kind":"person","name":"SAPIRSTEIN JAMES","position":1,"cik":"0001559509","reported_name":"SAPIRSTEIN JAMES","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-01T21:10:19.000Z","date":"2023-05-31","kind":"grant","planned":false,"acquired":true,"shares":6360,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a restricted stock award granted to the Reporting Person pursuant to the Issuer's 2022 Equity Incentive Plan, as amended. The award will vest in full on May 31, 2024 so long as the Reporting Person continues to serve as a non-employee director of the Issuer until such date."}],"balance_after":6360,"source":{"system":"sec-edgar","filing":"0001213900-23-045323","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1559509/000121390023045323/ownership.xml","form_type":"4"}},{"id":1896374,"issuer":{"id":8471,"kind":"organization","name":"Onconetix, Inc."},"owners":[{"id":56213,"kind":"person","name":"Hernandez Joseph","position":1,"cik":"0001598384","reported_name":"Hernandez Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2023-05-11T21:22:57.000Z","date":"2023-05-09","kind":"grant","planned":false,"acquired":true,"shares":150000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The restricted stock award was granted pursuant to the Blue Water Biotech, Inc. Amended and Restated 2022 Equity Incentive Plan. 50% of the stock award will vest on August 17, 2023; 25% of the award will vest on August 17, 2024; and the remaining 25% of the award will vest on August 18, 2025."}],"balance_after":2800351,"source":{"system":"sec-edgar","filing":"0001213900-23-038670","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1598384/000121390023038670/ownership.xml","form_type":"4"}},{"id":1896487,"issuer":{"id":8471,"kind":"organization","name":"Onconetix, Inc."},"owners":[{"id":113616,"kind":"person","name":"Garfield Jon","position":1,"cik":"0001336751","reported_name":"Garfield Jon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-05-11T21:21:00.000Z","date":"2023-05-09","kind":"grant","planned":false,"acquired":true,"shares":100000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The restricted stock award was granted pursuant to the Blue Water Biotech, Inc. Amended and Restated 2022 Equity Incentive Plan. 50% of the stock award will vest on August 17, 2023; 25% of the award will vest on August 17, 2024; and the remaining 25% of the award will vest on August 18, 2025."}],"balance_after":100000,"source":{"system":"sec-edgar","filing":"0001213900-23-038668","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1336751/000121390023038668/ownership.xml","form_type":"4"}},{"id":1896930,"issuer":{"id":8471,"kind":"organization","name":"Onconetix, Inc."},"owners":[{"id":113643,"kind":"person","name":"Henderson Erin","position":1,"cik":"0001895467","reported_name":"Henderson Erin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2023-05-11T21:18:57.000Z","date":"2023-05-09","kind":"grant","planned":false,"acquired":true,"shares":150000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The restricted stock award was granted pursuant to the Blue Water Biotech, Inc. Amended and Restated 2022 Equity Incentive Plan. 50% of the stock award will vest on August 17, 2023; 25% of the award will vest on August 17, 2024; and the remaining 25% of the award will vest on August 18, 2025."}],"balance_after":174752,"source":{"system":"sec-edgar","filing":"0001213900-23-038666","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1895467/000121390023038666/ownership.xml","form_type":"4"}},{"id":1920713,"issuer":{"id":8471,"kind":"organization","name":"Onconetix, Inc."},"owners":[{"id":114509,"kind":"organization","name":"Cincinnati Cornerstone Investors BWV I, LLC","position":1,"cik":"0001780627","reported_name":"Cincinnati Cornerstone Investors BWV I, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114510,"kind":"organization","name":"Cincinnati Cornerstone Capital LLC","position":2,"cik":"0001788977","reported_name":"Cincinnati Cornerstone Capital LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Manager-Cinti Cornerstone Inv."}}],"security":"Common Stock","published_at":"2023-04-12T11:06:27.000Z","date":"2023-04-10","kind":"other","planned":false,"acquired":false,"shares":1200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Distribution of Issuer Common Stock pursuant to a pro rata distribution by Cincinnati Cornerstone Investors BWV I, LLC."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Cincinnati Cornerstone Capital, LLC, as the manager and a member of Cincinnati Cornerstone Investors BWV I, LLC, beneficially owns the reported securities indirectly, but disclaims beneficial ownership of the reported securities, except to the extent of its pecuniary interest therein."}],"balance_after":1161201,"source":{"system":"sec-edgar","filing":"0000906318-23-000001","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1780627/000090631823000001/primary_doc.xml","form_type":"4"}},{"id":2041789,"issuer":{"id":8471,"kind":"organization","name":"Onconetix, Inc."},"owners":[{"id":42231,"kind":"person","name":"Ramdeen Timothy R.","position":1,"cik":"0001962363","reported_name":"Ramdeen Timothy R.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2023-01-30T17:12:18.000Z","date":"2023-01-26","kind":"grant","acquired":true,"shares":2386,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Stock options (the \"Options\") were granted to Mr. Ramdeen on January 26, 2023. 597 of the Options will vest and become exercisable on each of February 13, 2023, March 13, 2023 and April 13, 2023. The remaining 595 Options will vest on May 13, 2023."}],"balance_after":2386,"derivative":{"exercise_price":1.29,"exercise_date":"2023-02-13","expiration_date":"2033-02-12","underlying":"Common Stock","underlying_shares":2386},"source":{"system":"sec-edgar","filing":"0001213900-23-005891","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1782107/000121390023005891/ownership.xml","form_type":"4"}},{"id":2108160,"issuer":{"id":8471,"kind":"organization","name":"Onconetix, Inc."},"owners":[{"id":114509,"kind":"organization","name":"Cincinnati Cornerstone Investors BWV I, LLC","position":1,"cik":"0001780627","reported_name":"Cincinnati Cornerstone Investors BWV I, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114510,"kind":"organization","name":"Cincinnati Cornerstone Capital LLC","position":2,"cik":"0001788977","reported_name":"Cincinnati Cornerstone Capital LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Manager-Cinti Cornerstone Inv."}}],"security":"Common Stock","published_at":"2022-11-21T11:34:06.000Z","date":"2022-11-17","kind":"other","acquired":false,"shares":750000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Distribution of Issuer Common Stock pursuant to a pro rata distribution by Cincinnati Cornerstone Investors BWV I, LLC."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Cincinnati Cornerstone Capital, LLC, as the manager and a member of Cincinnati Cornerstone Investors BWV I, LLC, beneficially owns the reported securities indirectly, but disclaims beneficial ownership of the reported securities, except to the extent of its pecuniary interest therein."}],"balance_after":2361201,"source":{"system":"sec-edgar","filing":"0000906318-22-000006","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1780627/000090631822000006/primary_doc.xml","form_type":"4"}},{"id":2120810,"issuer":{"id":8471,"kind":"organization","name":"Onconetix, Inc."},"owners":[{"id":47712,"kind":"person","name":"Jeremic Vuk","position":1,"cik":"0001953202","reported_name":"Jeremic Vuk","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2022-11-09T21:05:25.000Z","date":"2022-11-08","kind":"grant","acquired":true,"shares":3610,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Stock options (the \"Options\") were granted to Mr. Jeremic on November 8, 2022. The Options vest and become exercisable in 6 equal monthly installments beginning on December 8, 2022 and ending on May 31, 2023."}],"balance_after":3610,"derivative":{"exercise_price":1.06,"exercise_date":"2022-12-08","expiration_date":"2032-11-07","underlying":"Common Stock","underlying_shares":3610},"source":{"system":"sec-edgar","filing":"0001213900-22-070595","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1782107/000121390022070595/ownership.xml","form_type":"4"}},{"id":2171399,"issuer":{"id":8471,"kind":"organization","name":"Onconetix, Inc."},"owners":[{"id":114509,"kind":"organization","name":"Cincinnati Cornerstone Investors BWV I, LLC","position":1,"cik":"0001780627","reported_name":"Cincinnati Cornerstone Investors BWV I, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114510,"kind":"organization","name":"Cincinnati Cornerstone Capital LLC","position":2,"cik":"0001788977","reported_name":"Cincinnati Cornerstone Capital LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Manager-Cinti Cornerstone Inv."}}],"security":"Common Stock","published_at":"2022-08-29T14:26:56.000Z","date":"2022-08-25","kind":"other","acquired":false,"shares":500000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Distribution of Issuer Common Stock pursuant to a pro rata distribution by Cincinnati Cornerstone Investors BWV I, LLC."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Cincinnati Cornerstone Capital, LLC, as the manager and a member of Cincinnati Cornerstone Investors BWV I, LLC, beneficially owns the reported securities indirectly, but disclaims beneficial ownership of the reported securities, except to the extent of its pecuniary interest therein."}],"balance_after":3111201,"source":{"system":"sec-edgar","filing":"0000906318-22-000004","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1780627/000090631822000004/primary_doc.xml","form_type":"4"}},{"id":2175156,"issuer":{"id":8471,"kind":"organization","name":"Onconetix, Inc."},"owners":[{"id":76342,"kind":"person","name":"Tarsh Simon","position":1,"cik":"0001943931","reported_name":"Tarsh Simon","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2022-08-24T16:27:18.000Z","date":"2022-08-22","kind":"grant","acquired":true,"shares":4073,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Stock options (the \"Options\") were granted to Mr. Tarsh on August 22, 2022. The Options vest and become exercisable in 9 monthly installments beginning on September 22, 2022."}],"balance_after":4073,"derivative":{"exercise_price":3.48,"exercise_date":"2022-09-22","expiration_date":"2032-08-22","underlying":"Common Stock","underlying_shares":4073},"source":{"system":"sec-edgar","filing":"0001213900-22-050780","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1943931/000121390022050780/ownership.xml","form_type":"4"}},{"id":2175750,"issuer":{"id":8471,"kind":"organization","name":"Onconetix, Inc."},"owners":[{"id":20771,"kind":"person","name":"Shaw Allan","position":1,"cik":"0001626850","reported_name":"Shaw Allan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2022-08-23T20:39:56.000Z","date":"2022-08-19","kind":"tax_withholding","acquired":false,"shares":29636,"price":0.01,"value":296.36,"ownership":{"direct":true},"balance_after":16284,"derivative":{"exercise_price":0.01,"exercise_date":"2020-01-14","expiration_date":"2030-01-14","underlying":"Common Stock","underlying_shares":29636},"source":{"system":"sec-edgar","filing":"0001213900-22-050550","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1626850/000121390022050550/ownership.xml","form_type":"4"}},{"id":2175749,"issuer":{"id":8471,"kind":"organization","name":"Onconetix, Inc."},"owners":[{"id":20771,"kind":"person","name":"Shaw Allan","position":1,"cik":"0001626850","reported_name":"Shaw Allan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-08-23T20:39:56.000Z","date":"2022-08-19","kind":"sale","acquired":false,"shares":29636,"price":3.94,"value":116765.84,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Common Stock reported herein were sold by the reporting person at a high price of $4.02, a low price of $3.91 and an average price of $3.94 per share of Common Stock. Upon request, the reporting person will provide details of each sale."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001213900-22-050550","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1626850/000121390022050550/ownership.xml","form_type":"4"}},{"id":2175748,"issuer":{"id":8471,"kind":"organization","name":"Onconetix, Inc."},"owners":[{"id":20771,"kind":"person","name":"Shaw Allan","position":1,"cik":"0001626850","reported_name":"Shaw Allan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-08-23T20:39:56.000Z","date":"2022-08-19","kind":"tax_withholding","acquired":true,"shares":29636,"price":0.01,"value":296.36,"ownership":{"direct":true},"balance_after":29636,"source":{"system":"sec-edgar","filing":"0001213900-22-050550","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1626850/000121390022050550/ownership.xml","form_type":"4"}},{"id":2176713,"issuer":{"id":8471,"kind":"organization","name":"Onconetix, Inc."},"owners":[{"id":56213,"kind":"person","name":"Hernandez Joseph","position":1,"cik":"0001598384","reported_name":"Hernandez Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2022-08-22T21:59:52.000Z","date":"2022-08-22","kind":"sale","acquired":false,"shares":30269,"price":4.1034,"value":124205.8146,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The Common Stock reported herein were sold by the reporting person at a high price of $4.22, a low price of $4.05 and an average price of $4.1034 per share of Common Stock. Upon request, the reporting person will provide details of each sale."}],"balance_after":2650351,"source":{"system":"sec-edgar","filing":"0001213900-22-050240","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1598384/000121390022050240/ownership.xml","form_type":"4"}},{"id":2176712,"issuer":{"id":8471,"kind":"organization","name":"Onconetix, Inc."},"owners":[{"id":56213,"kind":"person","name":"Hernandez Joseph","position":1,"cik":"0001598384","reported_name":"Hernandez Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2022-08-22T21:59:52.000Z","date":"2022-08-19","kind":"sale","acquired":false,"shares":76841,"price":4.2121,"value":323661.9761,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Common Stock reported herein were sold by the reporting person at a high price of $4.71, a low price of $4.05 and an average price of $4.2121 per share of Common Stock. Upon request, the reporting person will provide details of each sale."}],"balance_after":2680620,"source":{"system":"sec-edgar","filing":"0001213900-22-050240","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1598384/000121390022050240/ownership.xml","form_type":"4"}},{"id":2176711,"issuer":{"id":8471,"kind":"organization","name":"Onconetix, Inc."},"owners":[{"id":56213,"kind":"person","name":"Hernandez Joseph","position":1,"cik":"0001598384","reported_name":"Hernandez Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2022-08-22T21:59:52.000Z","date":"2022-08-18","kind":"sale","acquired":false,"shares":442539,"price":4.9551,"value":2192824.9989,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Common Stock reported herein were sold by the reporting person at a high price of $6.21, a low price of $4.16 and an average price of $4.9551 per share of Common Stock. Upon request, the reporting person will provide details of each sale."}],"balance_after":2757461,"source":{"system":"sec-edgar","filing":"0001213900-22-050240","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1598384/000121390022050240/ownership.xml","form_type":"4"}},{"id":2177187,"issuer":{"id":8471,"kind":"organization","name":"Onconetix, Inc."},"owners":[{"id":113643,"kind":"person","name":"Henderson Erin","position":1,"cik":"0001895467","reported_name":"Henderson Erin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Stock Option","published_at":"2022-08-22T21:59:43.000Z","date":"2022-08-19","kind":"tax_withholding","acquired":false,"shares":4834,"price":0.01,"value":48.34,"ownership":{"direct":true},"balance_after":16276,"derivative":{"exercise_price":0.01,"exercise_date":"2021-04-02","expiration_date":"2030-04-02","underlying":"Common Stock","underlying_shares":4834},"source":{"system":"sec-edgar","filing":"0001213900-22-050239","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1895467/000121390022050239/ownership.xml","form_type":"4"}},{"id":2177186,"issuer":{"id":8471,"kind":"organization","name":"Onconetix, Inc."},"owners":[{"id":113643,"kind":"person","name":"Henderson Erin","position":1,"cik":"0001895467","reported_name":"Henderson Erin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Stock Option","published_at":"2022-08-22T21:59:43.000Z","date":"2022-08-18","kind":"tax_withholding","acquired":false,"shares":24810,"price":0.01,"value":248.1,"ownership":{"direct":true},"balance_after":21110,"derivative":{"exercise_price":0.01,"exercise_date":"2021-04-02","expiration_date":"2030-04-02","underlying":"Common Stock","underlying_shares":24810},"source":{"system":"sec-edgar","filing":"0001213900-22-050239","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1895467/000121390022050239/ownership.xml","form_type":"4"}},{"id":2177185,"issuer":{"id":8471,"kind":"organization","name":"Onconetix, Inc."},"owners":[{"id":113643,"kind":"person","name":"Henderson Erin","position":1,"cik":"0001895467","reported_name":"Henderson Erin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2022-08-22T21:59:43.000Z","date":"2022-08-19","kind":"sale","acquired":false,"shares":4834,"price":3.97,"value":19190.98,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Common Stock reported herein were sold by the reporting person at a high price of $4.00, a low price of $3.96 and an average price of $3.97 per share of Common Stock. Upon request, the reporting person will provide details of each sale."}],"balance_after":24752,"source":{"system":"sec-edgar","filing":"0001213900-22-050239","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1895467/000121390022050239/ownership.xml","form_type":"4"}},{"id":2177184,"issuer":{"id":8471,"kind":"organization","name":"Onconetix, Inc."},"owners":[{"id":113643,"kind":"person","name":"Henderson Erin","position":1,"cik":"0001895467","reported_name":"Henderson Erin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2022-08-22T21:59:43.000Z","date":"2022-08-19","kind":"tax_withholding","acquired":true,"shares":4834,"price":0.01,"value":48.34,"ownership":{"direct":true},"balance_after":29586,"source":{"system":"sec-edgar","filing":"0001213900-22-050239","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1895467/000121390022050239/ownership.xml","form_type":"4"}},{"id":2177183,"issuer":{"id":8471,"kind":"organization","name":"Onconetix, Inc."},"owners":[{"id":113643,"kind":"person","name":"Henderson Erin","position":1,"cik":"0001895467","reported_name":"Henderson Erin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2022-08-22T21:59:43.000Z","date":"2022-08-18","kind":"tax_withholding","acquired":true,"shares":24752,"price":0.01,"value":247.52,"ownership":{"direct":true},"balance_after":24752,"source":{"system":"sec-edgar","filing":"0001213900-22-050239","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1895467/000121390022050239/ownership.xml","form_type":"4"}},{"id":2252711,"issuer":{"id":8471,"kind":"organization","name":"Onconetix, Inc."},"owners":[{"id":20771,"kind":"person","name":"Shaw Allan","position":1,"cik":"0001626850","reported_name":"Shaw Allan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2022-05-27T14:38:44.000Z","date":"2022-05-04","kind":"grant","acquired":true,"shares":4655,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Stock options (the \"Options\") were granted to Mr. Shaw on May 4, 2022. The Options vest and become exercisable as follows: (i) 774 of the Options vested immediately upon grant; (ii) 388 Options vest at the end of each calendar month from the date of issuance through February 28, 2023; and (iii) the remaining 389 Options vest on March 31, 2023."}],"balance_after":50575,"derivative":{"exercise_price":6.45,"expiration_date":"2032-05-04","underlying":"Common Stock, par value $0.00001 per share","underlying_shares":4655},"source":{"system":"sec-edgar","filing":"0001213900-22-029991","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1626850/000121390022029991/ownership.xml","form_type":"4"}},{"id":2252931,"issuer":{"id":8471,"kind":"organization","name":"Onconetix, Inc."},"owners":[{"id":113616,"kind":"person","name":"Garfield Jon","position":1,"cik":"0001336751","reported_name":"Garfield Jon","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2022-05-27T10:46:25.000Z","date":"2022-05-04","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Stock options (the \"Options\") were granted to Mr. Garfield on May 4, 2022. The Options vest and become exercisable as follows: 25% of the Options will vest on September 15, 2022 and the remainder of the Options vest in equal monthly installments over the following 36 months."}],"balance_after":100000,"derivative":{"exercise_price":6.45,"expiration_date":"2032-05-04","underlying":"Common Stock, par value $0.00001 per share","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001213900-22-030003","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1336751/000121390022030003/ownership.xml","form_type":"4"}},{"id":2253817,"issuer":{"id":8471,"kind":"organization","name":"Onconetix, Inc."},"owners":[{"id":126823,"kind":"person","name":"Venerable Michael","position":1,"cik":"0001895466","reported_name":"Venerable Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2022-05-27T10:44:38.000Z","date":"2022-05-04","kind":"grant","acquired":true,"shares":4655,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Stock options (the \"Options\") were granted to Mr. Venerable on May 4, 2022. The Options vest and become exercisable as follows: (i) 774 of the Options vested immediately upon grant; (ii) 388 Options vest at the end of each calendar month from the date of issuance through February 28, 2023; and (iii) the remaining 389 Options vest on March 31, 2023."}],"balance_after":4655,"derivative":{"exercise_price":6.45,"expiration_date":"2032-05-04","underlying":"Common Stock, par value $0.00001 per share","underlying_shares":4655},"source":{"system":"sec-edgar","filing":"0001213900-22-030001","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1895466/000121390022030001/ownership.xml","form_type":"4"}},{"id":2253639,"issuer":{"id":8471,"kind":"organization","name":"Onconetix, Inc."},"owners":[{"id":87344,"kind":"person","name":"Murphy Kimberly M","position":1,"cik":"0001810474","reported_name":"Murphy Kimberly M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2022-05-27T10:43:39.000Z","date":"2022-05-04","kind":"grant","acquired":true,"shares":4655,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Stock options (the \"Options\") were granted to Ms. Murphy on May 4, 2022. The Options vest and become exercisable as follows: (i) 774 of the Options vested immediately upon grant; (ii) 388 Options vest at the end of each calendar month from the date of issuance through February 28, 2023; and (iii) the remaining 389 Options vest on March 31, 2023."}],"balance_after":50575,"derivative":{"exercise_price":6.45,"expiration_date":"2032-05-04","underlying":"Common Stock, par value $0.00001 per share","underlying_shares":4655},"source":{"system":"sec-edgar","filing":"0001213900-22-029999","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1810474/000121390022029999/ownership.xml","form_type":"4"}},{"id":2252737,"issuer":{"id":8471,"kind":"organization","name":"Onconetix, Inc."},"owners":[{"id":56213,"kind":"person","name":"Hernandez Joseph","position":1,"cik":"0001598384","reported_name":"Hernandez Joseph","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO"}}],"security":"Stock Option","published_at":"2022-05-27T10:42:43.000Z","date":"2022-05-04","kind":"grant","acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Stock options (the \"Options\") were granted to Mr. Hernandez on May 4, 2022. The Options vest and become exercisable as follows (i) 174,972 Options vested immediately upon grant; (ii) 4,171 Options vest at the end of each calendar month from the date of issuance through September 30, 2022 and (iii) the remaining 4,173 Options vest on October 30, 2022."}],"balance_after":200000,"derivative":{"exercise_price":6.45,"expiration_date":"2032-05-04","underlying":"Common Stock, par value $0.00001 per share","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001213900-22-029997","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1598384/000121390022029997/ownership.xml","form_type":"4"}},{"id":2252837,"issuer":{"id":8471,"kind":"organization","name":"Onconetix, Inc."},"owners":[{"id":41703,"kind":"person","name":"SAPIRSTEIN JAMES","position":1,"cik":"0001559509","reported_name":"SAPIRSTEIN JAMES","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2022-05-27T10:40:49.000Z","date":"2022-05-04","kind":"grant","acquired":true,"shares":50575,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Stock options (the \"Options\") were granted to Mr. Sapirstein on May 4, 2022. The Options vest and become exercisable as follows: (A) with respect to 45,920 of the Options: (i) 1,912 Options vested immediately upon grant; (ii) 956 Options vest at the end of each calendar month from the date of issuance through January 31, 2026 and (iii) the remaining 988 Options vest on February 28, 2026 and (B) with respect to 4,655 of the Options: (i) (1) 774 of the Options vested immediately upon grant; (ii) 388 Options vest at the end of each calendar month from the date of issuance through February 28, 2023 and (iii) the remaining 389 Options vest on March 31, 2023."}],"balance_after":50575,"derivative":{"exercise_price":6.45,"expiration_date":"2032-05-04","underlying":"Common Stock, par value $0.00001 per share","underlying_shares":50575},"source":{"system":"sec-edgar","filing":"0001213900-22-029995","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1559509/000121390022029995/ownership.xml","form_type":"4"}},{"id":2253818,"issuer":{"id":8471,"kind":"organization","name":"Onconetix, Inc."},"owners":[{"id":113643,"kind":"person","name":"Henderson Erin","position":1,"cik":"0001895467","reported_name":"Henderson Erin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Stock Option","published_at":"2022-05-27T10:39:39.000Z","date":"2022-05-04","kind":"grant","acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Stock options (the \"Options\") were granted to Ms. Henderson on May 4, 2022. The Options vest and become exercisable as follows (i) 127,800 Options vested immediately upon grant; (ii) 1,306 Options vest at the end of each calendar month from the date of issuance through December 31, 2023 and (iii) 1,920 Options vest at the end of each calendar month thereafter through December 31, 2025."}],"balance_after":245920,"derivative":{"exercise_price":6.45,"expiration_date":"2032-05-04","underlying":"Common Stock, par value $0.00001 per share","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001213900-22-029993","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1895467/000121390022029993/ownership.xml","form_type":"4"}},{"id":2373886,"issuer":{"id":8471,"kind":"organization","name":"Onconetix, Inc."},"owners":[{"id":114509,"kind":"organization","name":"Cincinnati Cornerstone Investors BWV I, LLC","position":1,"cik":"0001780627","reported_name":"Cincinnati Cornerstone Investors BWV I, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114510,"kind":"organization","name":"Cincinnati Cornerstone Capital LLC","position":2,"cik":"0001788977","reported_name":"Cincinnati Cornerstone Capital LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series Seed Preferred Stock","published_at":"2022-02-24T15:46:33.000Z","date":"2022-02-23","kind":"exercise","acquired":false,"shares":735632,"price":6.09,"value":4479998.88,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Series Seed Preferred Stock and all related accrued and unpaid dividends automatically converted into Common Stock, as previously agreed, upon the closing of the initial public offering of the Issuer. The Series Seed Preferred Stock was convertible at any time and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Series Seed Preferred Stock and all related accrued and unpaid dividends automatically converted into Common Stock, as previously agreed, upon the closing of the initial public offering of the Issuer. The Series Seed Preferred Stock was convertible at any time and had no expiration date."}],"balance_after":0,"derivative":{"exercise_price":1.5225,"underlying":"Common Stock","underlying_shares":3611201},"source":{"system":"sec-edgar","filing":"0001829126-22-004379","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1780627/000182912622004379/ownership.xml","form_type":"4"}},{"id":2373885,"issuer":{"id":8471,"kind":"organization","name":"Onconetix, Inc."},"owners":[{"id":114509,"kind":"organization","name":"Cincinnati Cornerstone Investors BWV I, LLC","position":1,"cik":"0001780627","reported_name":"Cincinnati Cornerstone Investors BWV I, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114510,"kind":"organization","name":"Cincinnati Cornerstone Capital LLC","position":2,"cik":"0001788977","reported_name":"Cincinnati Cornerstone Capital LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-02-24T15:46:33.000Z","date":"2022-02-23","kind":"exercise","acquired":true,"shares":3611201,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Series Seed Preferred Stock and all related accrued and unpaid dividends automatically converted into Common Stock, as previously agreed, upon the closing of the initial public offering of the Issuer. The Series Seed Preferred Stock was convertible at any time and had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Cincinnati Cornerstone Capital, LLC, as the manager and a member of Cincinnati Cornerstone Investors BWV I, LLC, beneficially owns the reported securities indirectly, but disclaims beneficial ownership of the reported securities, except to the extent of its pecuniary interest therein."}],"balance_after":3611201,"source":{"system":"sec-edgar","filing":"0001829126-22-004379","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1780627/000182912622004379/ownership.xml","form_type":"4"}}]}